Zolgensma is a gene therapy that has been engineered to contain the SMN1 gene. Treatments like Zolgensma can quickly increase the levels of available SMA protein in the body after administration. Some irreversible damage may have already occurred to the motor neurons that have been without enough SMA protein for some time. This may happen even before a baby is born.